Cargando…
Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis
INTRODUCTION: The advent of biological and targeted synthetic therapies has revolutionized rheumatoid arthritis (RA) treatment. However, this has come at the price of an increased risk of infections. The aim of this study was to present an integrated overview of both serious and non-serious infectio...
Autores principales: | Bergmans, Barbara J. M., Gebeyehu, Biniyam Y., van Puijenbroek, Eugène P., Van Deun, Katrijn, Kleinberg, Bennett, Murk, Jean-Luc, de Vries, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469142/ https://www.ncbi.nlm.nih.gov/pubmed/37365454 http://dx.doi.org/10.1007/s40744-023-00571-z |
Ejemplares similares
-
Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
por: Laine, Christopher G., et al.
Publicado: (2020) -
Scoping Pharmacy Students’ Learning Outcomes: Where Do We Stand?
por: Pires, Carla, et al.
Publicado: (2019) -
A Scoping Review of Sleep Apnea: Where Do We Stand?
por: Hirani, Rahim, et al.
Publicado: (2023) -
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?
por: Romão, Vasco Crispim, et al.
Publicado: (2013) -
Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand?
por: Halilova, Karina I., et al.
Publicado: (2012)